Suppr超能文献

常见的差异表达基因的表观遗传修饰导致癌症适应性耐药。

Commonly integrated epigenetic modifications of differentially expressed genes lead to adaptive resistance in cancer.

机构信息

Dermatology Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, QLD, Australia.

Centenary Institute of Cancer Medicine & Cell Biology, University of Sydney, Camperdown, NSW, Australia.

出版信息

Epigenomics. 2019 May;11(7):732-737. doi: 10.2217/epi-2018-0173. Epub 2019 May 9.

Abstract

To investigate the integrated epigenetic regulation of acquired drug resistance in cancer. Our gene expression data of five induced drug-tolerant cell models, one resistant cell line and one publicly available drug-resistant dataset were integrated to identify common differentially expressed genes and pathways. ChIP-seq and DNA methylation by HM450K beadchip were used to study the epigenetic profile of differential expressed genes. Integrated transcriptomic analysis identified a common 'viral mimicry' related gene signature in induced drug-tolerant cells and the resistant state. Analysis of the epigenetic regulation revealed a common set of down-regulated genes, which are marked and regulated by a concomitant loss of H3K4me3, gain of H3K9me3 and increment of regional DNA methylation levels associated with tumor suppressor genes and apoptotic signaling.

摘要

研究获得性药物耐药性的综合表观遗传调控。我们整合了五个诱导耐药细胞模型、一个耐药细胞系和一个公开的耐药数据集的基因表达数据,以鉴定共同差异表达的基因和途径。使用 ChIP-seq 和 HM450K 珠芯片进行 DNA 甲基化研究差异表达基因的表观遗传特征。综合转录组分析在诱导耐药细胞和耐药状态中鉴定出一个共同的“病毒模拟”相关基因特征。表观遗传调控分析揭示了一组共同下调的基因,这些基因被标记并受 H3K4me3 的伴随丢失、H3K9me3 的获得以及与肿瘤抑制基因和凋亡信号相关的区域性 DNA 甲基化水平的增加调节。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b1e1/6595545/0f452c2aa3d1/epi-11-723-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验